Sunday, August 2, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan DisruptiontodayDEFENSEPentagon's $500M Counter-Drone Contract Is a Direct Revenue Line for AeroVironment — and Pressure on Its Rivals4 weeks agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected MarkettodayWHITE HOUSETrump's Quantum Executive Orders Set a 2030 Deadline — and a Spending Clock for IonQ, Rigetti, and the Cybersecurity Stack4 weeks agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in RevenuetodayHEALTHCARE & FDAMedicare Starts Covering GLP-1 Weight-Loss Drugs July 1 — Novo Nordisk and Eli Lilly Just Got 67 Million New Potential Customers4 weeks agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers WintodayCRYPTOBitcoin ETF Outflows Hit $4.3 Billion in June — Coinbase, MARA, and Strategy Are Carrying the Most Risk4 weeks agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal BackingyesterdayDEFENSEHegseth's NATO Broadside and Europe Force Review Signal a Shift That Benefits U.S. Primes — at Europe's Expense4 weeks agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on WindfallyesterdayHEALTHCARE & FDAMedicare Is Now Covering Wegovy — Novo Nordisk and Eli Lilly Just Got a Massive New Payer4 weeks agoSEARCH DEMANDData Center Power ExchangeyesterdayHEALTHCARE & FDAFDA Expands Casgevy to Toddlers — Vertex and CRISPR Therapeutics Just Got a Bigger Market4 weeks agoSEARCH DEMANDCasgevy List Price: $2.2 MillionyesterdayCRYPTOBitcoin Is Down 33% at Mid-Year and ETF Outflows Hit $4.3B in June — Coinbase and the Miners Are Feeling It4 weeks agoENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors2 days agoENERGYWashington Is Rewriting Nuclear Radiation Safety Rules — Constellation, Vistra, and the SMR Crowd All Win4 weeks agoMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue2 days agoWHITE HOUSETrump's Quantum Executive Order Sets a Hard Deadline — and Quantum Computing Stocks Are the Immediate Beneficiary4 weeks agoDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue2 days agoDEFENSEHegseth's NATO Broadside and European Force Review Put Defense Primes in a Complicated Spot4 weeks agoDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue3 days agoTECHCommerce Department's AI Model Export Controls Are the Next Nvidia Headwind — and AMD Isn't Immune4 weeks agoHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem4 days agoTRADE & TARIFFSNike's Tariff Refunds Are a One-Time Boost, Not a Structural Fix — Here's What the Q4 Beat Actually Means4 weeks agoCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity4 days agoENERGYThe US-Iran Initial Deal Puts Sanction Relief on the Table — and That's a Headwind for Oil Prices and E&P Stocks4 weeks agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue4 days agoHEALTHCARE & FDAFDA Expands Casgevy to Kids as Young as 2 — Vertex and CRISPR Therapeutics Get a Bigger Market4 weeks agoDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation4 days agoTECHTrump's Post-Quantum Cryptography Executive Order Creates a Compliance Spending Mandate — and Clear Beneficiaries4 weeks agoHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten5 days agoTRADE & TARIFFSNike's Tariff Refund Windfall Shows How Import-Heavy Brands Can Turn Trade Policy Into a Margin Story4 weeks agoDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset5 days agoDEFENSEPentagon's $500M Counter-Drone Contract Is a Direct Revenue Line for AeroVironment4 weeks agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years5 days agoHEALTHCARE & FDAFDA's BHT and ADA Reassessment Puts Food Additive Users on Notice — and Creates an Opening for Clean-Label Suppliers4 weeks agoDEFENSEHouse Passes $1.15 Trillion Defense Bill—Lockheed, Raytheon, and General Dynamics Positioned for Record Spending6 days agoENERGYMissouri Joins Federal Nuclear Fast-Track Program, Adding Momentum to the SMR Buildout Trade4 weeks agoHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—UnitedHealth, Humana, and Anthem Positioned to Gain from Simplified Metrics6 days agoDEFENSEThe US-Iran Ceasefire Deal Pressures Oil Prices — and Reshuffles the Defense Trade4 weeks agoTECHFCC Tightens Submarine Cable Licensing Rules—Tech Giants Face New Compliance Costs, Telecom Carriers Gain Regulatory Clarity6 days agoHEALTHCARE & FDAFDA Expands Casgevy to Children as Young as 2, Widening the Market for Vertex and CRISPR Therapeutics4 weeks agoDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Direct Win for Oracle, Pressure on Smaller Defense IT Rivals6 days agoCRYPTOCrypto Clarity Act Progress and SEC's ETF Rule Review Are the Two Biggest Near-Term Catalysts for Coinbase and Robinhood4 weeks agoDEFENSEPentagon's $7B Oracle Software Deal Is One of the Cleanest Defense-Tech Wins in Yearslast weekDEFENSENATO's Spending Surge Is Real — and the US Defense Primes Are the Ones Getting Paid4 weeks agoMARKETSChina's $765M Antitrust Fine on Trip.com Is a Warning Shot for U.S.-Listed Chinese Consumer Stockslast weekDEFENSEPentagon's $500M Counter-Drone Contract Is a Direct Payday for AeroVironment4 weeks agoTRADE & TARIFFSTariffs on Indian Pharma Are Coming — and U.S. Generic Drug Buyers Will Pay the Billlast weekTECHTrump's Quantum Computing Executive Orders Create a Policy Tailwind for a Handful of Public Names4 weeks agoHEALTHCARE & FDACMS's Star Ratings Overhaul Rescues the Biggest Medicare Advantage Insurers — For Nowlast weekHEALTHCARE & FDAMedicare Starts Covering GLP-1 Obesity Drugs — Novo Nordisk and Eli Lilly Are the Direct Winners4 weeks agoCRYPTOThe Senate's Landmark Crypto Bill Creates Winners Inside the ETF and Exchange Stacklast weekTECHWhite House Lifts Export Controls on Anthropic's Advanced AI Models — Nvidia and AMD Are the Coattail Trade4 weeks agoWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Military Supply Chain — These Miners Fill the Gaplast weekCRYPTOSEC Commissioner Signals Crypto Clarity Act Could Pass This Summer — Coinbase and Robinhood Are the Clearest Beneficiaries4 weeks agoDEFENSEOracle Lands a $7B Pentagon Software Contract — and the Market Should Take It Seriouslylast weekDEFENSENATO's 'Report Card' Pressure Means Years of European Defense Spending — RTX and Lockheed Are the First Calls4 weeks agoDEFENSEThe U.S.-Iran War Is Costing $37.5B and Counting — Here's Where That Money Goeslast weekHEALTHCARE & FDAFDA Clears Casgevy for Toddlers with Sickle Cell — Vertex and CRISPR Therapeutics Get a Bigger Market4 weeks agoENERGYTrump Signs the Saudi Nuclear Deal — and U.S. Uranium and Reactor Companies Are the Quiet Winnerslast weekENERGYMissouri Joins Federal Nuclear Fast-Track Program as State-Level Momentum Builds — Constellation, Vistra, and Oklo Are the Plays4 weeks agoENERGYNRC Approves Holtec's Upgraded Spent Fuel Storage System — A Quiet Win for Nuclear's Capacity Expansionlast weekENERGYU.S.-Iran Initial Deal Eases Sanctions Pressure — Oil Prices Face a Ceiling, E&P Stocks Feel It4 weeks agoDEFENSEHouse Passes $1.15T Defense Bill — Missile Defense, Shipbuilding, and Next-Gen Air Get the Moneylast weekHEALTHCARE & FDAFDA Expands Casgevy to Kids as Young as 2 — Vertex and CRISPR Therapeutics Get a Bigger Market3 weeks agoTRADE & TARIFFSTrump's 50% Canada Tariff Threat Keeps U.S. Aluminum Tight — Domestic Producers Win, Manufacturers Paylast weekHEALTHCARE & FDAMedicare Covering Obesity Drugs for the First Time Is a Direct Volume Catalyst for Novo Nordisk and Eli Lilly3 weeks agoENERGYTrump's Saudi Nuclear Pact Without Enrichment Safeguards Heads to Congress — U.S. Uranium and Nuclear Services Names Are the Playlast weekHEALTHCARE & FDAElevance Suing CMS Over Medicare Advantage Stars Is a Warning Sign for the Entire Managed Care Sector3 weeks agoTECHBosch's $225M CHIPS Act Award for Roseville Chips Away at U.S. Dependence on Asian Auto Semiconductorslast weekTECHWhite House Quantum Summit and Accelerated PQC Deadlines Create a Spending Runway for IonQ and IBM3 weeks agoHEALTHCARE & FDACMS Freezes $1 Billion in Medicaid Payments to California and Minnesota — Managed Care Insurers Face Revenue Gapslast weekCRYPTOSEC's Pending Crypto Safe Harbor Rule Is the Clearest Regulatory Tailwind Coinbase Has Seen in Years3 weeks agoCRYPTOWhite House Concedes Ethics Provision in Crypto Bill — Clearing the Last Roadblock for Stablecoin Legislationlast weekDEFENSENATO's 3.5% GDP Spending Push Sends a Long-Term Revenue Signal to Raytheon, Lockheed, and Northrop3 weeks agoWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Defense Supply Chain — and Sends Money to U.S. Minerslast weekENERGYCommonwealth LNG Permit Review Opens a New Export Capacity Race — Cheniere Holds the Pole Position3 weeks agoDEFENSEPentagon's $80M Drone Defense Contract Points to the Counter-UAS Names Worth Watchinglast weekTECHTrump Accelerates Post-Quantum Encryption Deadlines — and a Handful of Small-Cap Security Firms Are the Direct Beneficiaries3 weeks agoDEFENSEU.S.-Iran Conflict Escalation Stalls Hormuz Shipping — Defense Contractors and Oil Majors Are the Immediate Readlast weekTRADE & TARIFFSTariff Tailwinds Are Still Running for U.S. Metals — but the Easy Money in Steel and Aluminum May Already Be Priced3 weeks agoENERGYNew Jersey's Nuclear Energy Law Opens a Real Revenue Path for Small Reactor Developerslast weekMARKETSFTC Forces John Deere to Open Its Repair Ecosystem — and the Aftermarket Parts Industry Wins3 weeks agoWHITE HOUSETrump's Defense Supply Chain Order Tightens Waiver Rules — Domestic Parts Makers Win, Foreign-Sourced Primes Face Frictionlast weekTRADE & TARIFFSMcCormick's $28M Tariff Refund Is a One-Time Cushion — the Underlying Cost Pressure Hasn't Gone Away3 weeks agoENERGYNew Mexico's Pipeline Denial Puts Oracle's Data Center Expansion on Ice — and Highlights Every Hyperscaler's Power Risklast weekDEFENSENATO's 3.5% GDP Spending Push Is a Multi-Year Order Book for U.S. Defense Primes3 weeks agoTECHBosch's $225M CHIPS Award for Silicon Carbide Chips Is a Direct Threat to Wolfspeed's U.S. Market Sharelast weekENERGYFederal Proposal to Streamline Nuclear Environmental Reviews Cuts Years Off the SMR Timeline3 weeks agoWHITE HOUSEWhite House Control Over Frontier AI Access Reshapes Who Wins the Model Racelast weekHEALTHCARE & FDAMedicare Starts Covering Obesity Drugs — Novo Nordisk and Eli Lilly Just Got 67 Million New Potential Customers3 weeks agoDEFENSEU.S.-Iran Escalation and a Stalled Strait of Hormuz Are a Windfall for Tanker Owners and Defense Primeslast weekENERGYCommonwealth LNG Permit Review Opens — Another Export Terminal in the Queue Benefits the Whole LNG Supply Chain3 weeks agoHEALTHCARE & FDACMS's Site-Neutral and 340B Reform Proposal Squeezes Hospital Margins and Lifts Independent Pharmacieslast weekENERGYUSDA's Revamped Biorefinery Loan Guarantee Program Is a Quiet Tailwind for ADM and Renewable Chemical Producers3 weeks agoHEALTHCARE & FDACMS's Site-Neutral and 340B Cuts Would Squeeze Hospital Systems and Hand Wins to Outpatient Rivals2 weeks agoHEALTHCARE & FDATrump's Proposed Medicare Drug Savings Rule Puts PBMs in the Crosshairs — and Gives Pharma a Mixed Signal3 weeks agoCRYPTOT. Rowe Price's Active Multi-Token Crypto ETF Is a Fee Story — and a Pressure Test for Bitwise and Grayscale2 weeks agoTRADE & TARIFFSDeepSeek's Custom Chip Gambit Is a Direct Threat to Nvidia's China Revenue — and a Warning for AMD3 weeks agoWHITE HOUSEWhite House Control Over Frontier AI Access Reshapes the Pecking Order — Microsoft and Oracle Gain, Open-Source Loses2 weeks agoENERGYFederal Proposal to Streamline Nuclear Environmental Reviews Cuts the Clock for SMR Developers3 weeks agoWHITE HOUSEWhite House Cybersecurity Clearinghouse Creates a Direct Revenue Line for CrowdStrike, Palantir, and Microsoft2 weeks agoDEFENSENATO's Spending Surge Is Real and Getting Enforced — RTX, Lockheed, and AeroVironment Are the Direct Beneficiaries3 weeks agoENERGYMichigan's Line 5 Permit Renewal Is a Clear Win for Enbridge — and a Setback for Pipeline Opponents2 weeks agoENERGYCommonwealth LNG Permit Moves Forward — Cheniere and ConocoPhillips Are Watching Closely3 weeks agoCRYPTOT. Rowe Price's Active Multi-Token Crypto ETF Is a Fee-War Warning Shot for Bitwise and Grayscale2 weeks agoHEALTHCARE & FDAFDA Clears Casgevy for Toddlers — Vertex and CRISPR Therapeutics Just Doubled Their Addressable Market3 weeks agoDEFENSEPentagon's Laser Weapon Contracts for Drone Defense Open a New Revenue Line for Northrop and L3Harris2 weeks agoMARKETSFTC Forces John Deere to Open Its Repair Tools — Farmers Win, Deere's Software Moat Takes a Hit3 weeks agoTECHBosch's $225M CHIPS Award for Silicon Carbide Puts Wolfspeed and Onsemi on Notice2 weeks agoCRYPTOThe SEC's 2026 Crypto Regulatory Agenda Is a Green Light for Coinbase and Robinhood3 weeks agoENERGYMichigan Renews Enbridge's Line 5 Tunnel Permit, Removing the Biggest Regulatory Overhang on the Stock2 weeks agoENERGYFederal Nuclear Push Makes Centrus Energy's HALEU Monopoly More Valuable by the Month3 weeks agoENERGYNew Mexico Blocks Oracle's Data Center Gas Pipeline, Exposing the Fragility of Big Tech's Power Build-Out2 weeks agoHEALTHCARE & FDAFDA Clears Casgevy for Toddlers with Sickle Cell — Vertex and CRISPR Therapeutics Get a Bigger Market3 weeks agoENERGYTrump's Nuclear Push Is Driving a Real Uranium Mining Revival — These Are the Stocks That Collect2 weeks agoDEFENSENATO's 3.5% GDP Spending Push Is a Multi-Year Order Book for Lockheed, RTX, and Northrop3 weeks agoWHITE HOUSEWhite House 'Gold Eagle' AI Cyber Clearinghouse Is a Direct Revenue Signal for CrowdStrike and Palantir2 weeks agoTECHThe White House's $2 Billion Quantum Bet Has Clear Stock Winners — and a Cryptography Deadline That Hurts Laggards3 weeks agoDEFENSEPentagon's Laser Weapon Contracts for Drone Defense Hand a Direct Win to Directed-Energy Specialists2 weeks agoWHITE HOUSEFTC Forces Deere to Open Its Repair Tools — and Hands Independent Shops a Business Model3 weeks agoWHITE HOUSETrump Shrinks Two Utah Monuments by 90%, Opening Land to Mining and Drilling2 weeks agoENERGYFederal Proposal to Streamline Nuclear Environmental Reviews Cuts the Biggest Cost for SMR Developers3 weeks agoHEALTHCARE & FDACMS's Proposed 340B Payment Cuts Would Squeeze Hospital Revenue While Helping PBM Rivals2 weeks agoTRADE & TARIFFSDeepSeek's Custom Chip Gambit Is a Direct Threat to Nvidia's China Revenue — and a Warning for AMD3 weeks agoTRADE & TARIFFSPepsiCo's Tariff Refund Is a Small Win, But It Points to a Broader Cost Relief Story for Consumer Staples2 weeks agoHEALTHCARE & FDAMedicare Advantage Plans Are Set to Collect $13 Billion in Quality Bonuses — UnitedHealth and Humana Lead the Queue3 weeks agoDEFENSEJohnson's $95 Billion Defense Spending Plan Has Lockheed, RTX, and Northrop Written All Over It2 weeks agoCRYPTOVanguard's Crypto Pivot Signals Institutional Capitulation — Coinbase and Robinhood Are the Infrastructure Winners3 weeks agoDEFENSEThe UK's £300 Billion Defense Plan Is a Revenue Opportunity for U.S. Contractors — If They Can Win the Bids3 weeks agoWHITE HOUSETrump's Subpoenas of NYT Reporters Create Legal Overhang for News Publishers — and a Tailwind for First Amendment Litigators3 weeks agoENERGYPalisades Restart and Trump's Nuclear Push Are Turning Uranium Miners Into a Policy Trade3 weeks agoDEFENSENATO Members Racing to 3.5% GDP Defense Spending — U.S. Contractors Are the Biggest Beneficiaries3 weeks agoHEALTHCARE & FDAHHS Fraud Crackdown on Medicare Advantage Puts Managed Care Insurers and For-Profit Hospitals on Defense3 weeks agoCRYPTOThe CLARITY Act Could Redraw Crypto's Regulatory Map — Here's Which Public Names Win3 weeks agoTECHThe White House's $2 Billion Quantum Bet Has Clear Winners — and They're Already Public3 weeks agoENERGYPalisades Nuclear Restart and New SMR Plans Put Holtec — and Its Public Suppliers — in the Spotlight3 weeks agoTRADE & TARIFFSBIS Lifts Export Restrictions on UAE — Chip and Defense Tech Sellers Get a New Customer3 weeks agoMARKETSDOJ Kills TransDigm's $960M Deal — The Acquirer Takes the Hit, the Target Gets a Second Life3 weeks agoWHITE HOUSEESA 'Harm' Definition Rescinded — Extractive Industries Get Regulatory Relief, Conservation Stocks Face Uncertainty3 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

FDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win

Orange B and Citrus Red No. 2 face removal from food supply, opening market share for natural and synthetic alternatives.

Image: Money Racket
By at Money Racket · Aug 2, 2026
1-YEAR MOVE
+33% −6%
ADM ▲25.9%
1-year price move by ticker
TickerCompany1-year change
ADMArcher-Daniels-Midland+25.9%

The FDA has issued a final order revoking the use of Orange B as a food color additive and is proposing to revoke Citrus Red No. 2, both petroleum-based dyes. The action is part of the Trump administration's "Make America Healthy Again" initiative to modernize food safety regulations by eliminating outdated colorants.

Banning petroleum dyes forces food makers to switch to natural colorants, handing market share to Chr. Hansen and Sensient.

Who cashes in: Manufacturers of natural food colorants—including Chr. Hansen (CHR) (natural colors and ingredients), Sensient Technologies (SXT) (specialty colors and flavors), and Archer-Daniels-Midland ADM (food additives and natural ingredients)—stand to gain as food makers reformulate to replace banned dyes. Smaller natural color suppliers and startups in the clean-label space also benefit from regulatory tailwinds. Food companies will incur reformulation costs but can market products as "dye-free" or "naturally colored," a consumer-facing win.

Who's exposed: Suppliers of synthetic petroleum-based colorants face volume loss. However, most major food manufacturers have already shifted toward natural or synthetic alternatives due to consumer demand, so the regulatory impact is modest. Companies still relying on Orange B or Citrus Red No. 2 (primarily in niche products) will face reformulation costs.

What to watch next: Timeline for Citrus Red No. 2 final revocation, food company earnings calls for reformulation cost guidance, and whether other petroleum-based additives face similar scrutiny.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/fda-revokes-petroleum-color-additives-food-orange-b-citrus-red/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →